M. Jack Rudnick
Director, New York State Science & Technology Law Center
Professor of Practice, Syracuse University College of Law
J.D., Syracuse University College of Law
B.A., Middlebury College
Jack Rudnick is Director of the New York State Science and Technology Law Center and Syracuse University College of Law’s Technology Commercialization Law Program. He is an experienced corporate and intellectual property attorney who has been providing legal counsel for 40 years. He has extensive experience in commercializing new technologies and advising emerging technology companies. His interests are IP strategy development to maximize protection and return on investment and managing technology commercialization programs and ventures.
Rudnick began his career as in-house counsel, first at Oneida Ltd. and then at medical device manufacturer Welch Allyn, Inc. Rudnick co-founded Blue Highway, Inc. while at Welch Allyn to locate and accelerate the development of technologies with medical applications. He continued with Blue Highway after it was transferred to Syracuse University in the role of Senior Vice President, Legal and Government Affairs. He is currently of counsel with Barclay Damon, LLP’s Emerging Technology Team, where he provides business and legal consultation to technology-based companies. Prior to Professor Ghosh’s appointment, Rudnick served as the Director of the Technology Commercialization Law Program from 2013 to 2016.
He is an active member of several professional organizations and is on the Board of Trustees for the Everson Museum of Art. In addition, Rudnick serves on the Board of Directors for MedTech Association and the Central New York Community Foundation, Inc., the Advisory Board of the Lally School of Management’s M.S. in Technology Commercialization and Entrepreneurship at Rensselaer Polytechnic Institute (RPI), and the Board of Advisors of the CNY Biotech Accelerator. He received his JD from Syracuse University College of Law. He received his undergraduate degree from Middlebury College.